Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Strategy $2 billion convertible notes offering
The convertible notes are due 2030
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Eastman Chemical $250 million notes offering
The investment-grade notes are due 2029
PPL $2 billion at-the-market offering
We advised PPL on the offering
InflaRx $30 million offering of ordinary shares and pre-funded warrants
The ordinary shares are listed on the Nasdaq Global Market
Avianca senior secured notes offering and exchange offer and consent solicitation
The transactions included a $1 billion senior secured notes offering and a $1.1 billion exchange offer and consent solicitation
NeuroPace $74.75 million follow-on offering
The stock is listed on the Nasdaq Global Market
Oculis Holding $100 million follow-on equity offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Boston Gas $500 million senior notes offering
The investment-grade notes are due 2035
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction